{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:50:42Z","timestamp":1787147442993,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21390273"],"award-info":[{"award-number":["21390273"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jneuroim.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T21:00:34Z","timestamp":1315947634000},"page":"87-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1016","volume":"239","author":[{"given":"Motoi","family":"Kuwahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.08.016_bb0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1085-9489.2005.0010207.x","article-title":"Antibodies to peripheral nerve myelin proteins in cronic inflammatory demyelinating polyradicuroneuropathy","volume":"10","author":"Allen","year":"2005","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0010","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00315684","article-title":"Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulfatide of peripheral nerve myelin","volume":"238","author":"Fredman","year":"1991","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1529-8027.2002.02006.x","article-title":"Anti-LM1 antibodies in the sera of patients with Guillain\u2013Barr\u00e9 syndrome, Miller Fisher syndrome, and motor neuron disease","volume":"7","author":"Harukawa","year":"2002","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain\u2013Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain\u2013Barr\u00e9 syndrome and cronic inflammatory demyelinating polyneuropathy","volume":"107","author":"Ilyas","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1085-9489.2005.10302.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"Joint Task Force of the EFNS and the PNS","year":"2005","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes: as new target antigens in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/jnnp.2006.087940","article-title":"Anti-ganglioside complex antibodies in Miller Fisher syndrome","volume":"77","author":"Kaida","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","article-title":"Anti-ganglioside complex antibodies associated with severe disability in GBS","volume":"182","author":"Kaida","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0055","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","article-title":"GM1\/GalNAc-GD1a complex: a target for pure motor Guillain\u2013Barr\u00e9 syndromes","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jnr.20228","article-title":"Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells","volume":"78","author":"Kanda","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0065","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jnnp.2007.142950","article-title":"Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain\u2013Barr\u00e9 syndromes","volume":"79","author":"Kanzaki","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0070","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mus.880160710","article-title":"Localization of GM1 and GD1b antigens in the human peripheral nervous system","volume":"16","author":"Kusunoki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","article-title":"Immunological investigation of chronic inflammatory demyelinationg polyradiculoneuropathy","volume":"73","author":"Mel\u00e9ndez-V\u00e1squez","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2009.11.012","article-title":"Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies","volume":"219","author":"Nobile-Orazio","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.06.017","article-title":"Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain\u2013Barr\u00e9 syndromes","volume":"214","author":"Ogawa","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0090","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1471-4159.1992.tb11018.x","article-title":"Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from Cauda equine","volume":"59","author":"Ogawa-Goto","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-510X(02)00005-9","article-title":"Fine specificities of anti-LM1 IgG antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"195","author":"Susuki","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(99)00174-4","article-title":"Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain\u2013Barr\u00e9 syndrome","volume":"168","author":"Yako","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.08.016_bb0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811002335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811002335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:00Z","timestamp":1759047480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811002335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0165572811002335"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.08.016","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain\u2013Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}